Zydus Lifesciences informs about press release

22 Jul 2024 Evaluate

Zydus Lifesciences has informed that it enclosed a copy of press release dated July 22, 2024 titled ‘Zydus receives approval from COFEPRIS of Mexico to market Bhava™ (Bevacizumab biosimilar) to treat various cancers’.

The above information is a part of company’s filings submitted to BSE.


Zydus Lifesciences Share Price

978.00 4.10 (0.42%)
23-Dec-2024 11:26 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1823.00
Dr. Reddys Lab 1351.00
Cipla 1488.00
Lupin 2182.50
Zydus Lifesciences 978.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.